Latest squamous cell carcinoma Stories
Zoll, Kranz & Borgess, LLC, (ZKB) a pharmaceutical and medical device litigation firm, is currently investigating claims of men who developed melanoma after taking the pharmaceutical drug,
Trial Will Evaluate Investigational Compound's Efficacy and Safety as an Addition to Standard Chemotherapy in Previously-Untreated Patients NORTH CHICAGO, Ill., April 15, 2014 /PRNewswire/
A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers.
A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer.
New research report “NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool” worked out by
Markets Research Reports.biz added deep and professional market research reports on "NSCLC Therapeutics In Asia-Pacific Markets To 2019 - Personalized Therapies Focus On Untapped Segment
Public Can Get Free Screenings During Oral Head and Neck Cancer Awareness Week®, April 20-26 NEW YORK, March 20, 2014 /PRNewswire/ -- A first-of-its-kind study shows that sore throat
DALLAS, March 15, 2014 /PRNewswire/ -- ReportsnReports.com offers "Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation
Patient-friendly treatment helps minimize radiation exposure to healthy tissues LOS GATOS, Calif., March 5, 2014 /PRNewswire/ -- On January 14, a 67-year-old male patient received
The Sensus Healthcare SRT-100™ is a non-invasive skin cancer treatment system.
- The word or words serving to define another word or expression, as in a dictionary entry.